CPB(CPB)
CPB
Q3 2026 EPS Estimate
$0.40
Sep 2, 2026 · Reports before open
Revenue Estimate
$2.16B
FY2026E EPS$2.17
FY2027E EPS$1.95
Analyst Sentiment
Wall St. Consensus
Hold21 analysts·High coverage
40
Score
1 Buy (5%)11 Hold (52%)9 Sell (43%)
Rating Breakdown
Strong Buy
00%
Buy
15%
Hold
1152%
Sell
943%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$17.00
-25.2%
Consensus
$20.00
-12.0%
Bull
$28.00
+23.2%
12-Month Target Range21 analysts
$17.00$20.00$28.00
Current $22.73Consensus
Current Price
$22.73
Above Consensus
$2.73
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev-0.51%
EPS-10.25%
FY2028
Rev+0.46%
EPS+5.39%
FY2029
Rev+0.80%
EPS+8.58%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $9.77B | $9.72B | $9.76B | $9.84B | $9.89B |
| Low | $9.76B | $9.51B | $9.71B | $9.75B | $9.79B |
| High | $9.78B | $10.62B | $9.81B | $10.34B | $10.39B |
| EBITDA Avg | $1.71B | $1.71B | $1.71B | $1.73B | $1.74B |
| Low | $1.71B | $1.67B | $1.71B | $1.71B | $1.72B |
| High | $1.72B | $1.86B | $1.72B | $1.81B | $1.82B |
| EBIT Avg | $1.32B | $1.31B | $1.32B | $1.33B | $1.33B |
| Low | $1.32B | $1.28B | $1.31B | $1.32B | $1.32B |
| High | $1.32B | $1.43B | $1.32B | $1.39B | $1.40B |
| Net Income Avg | $654M | $596M | $639M | $670M | $640M |
| Low | $646M | $508M | $488M | $662M | $632M |
| High | $661M | $706M | $883M | $714M | $682M |
| EPS Avg | $2.17 | $1.95 | $2.06 | $2.23 | $2.13 |
| Low | $2.15 | $1.69 | $1.63 | $2.21 | $2.11 |
| High | $2.20 | $2.35 | $2.94 | $2.38 | $2.27 |
| Analysts (Rev / EPS) | 13 / 13 | 15 / 13 | 12 / 6 | 6 / 2 | 7 / 2 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $2.16B | $2.65B | $2.56B | $2.36B | $2.15B | $2.65B | $2.57B | $2.37B |
| Low | $2.13B | $2.62B | $2.53B | $2.34B | $2.13B | $2.63B | $2.54B | $2.35B |
| High | $2.28B | $2.69B | $2.61B | $2.42B | $2.20B | $2.71B | $2.63B | $2.43B |
| EBITDA Avg | $379M | $465M | $449M | $415M | $378M | $466M | $451M | $417M |
| Low | $373M | $460M | $444M | $411M | $374M | $461M | $446M | $412M |
| High | $400M | $472M | $459M | $424M | $386M | $476M | $461M | $426M |
| EBIT Avg | $291M | $357M | $345M | $319M | $290M | $358M | $347M | $320M |
| Low | $287M | $353M | $341M | $316M | $287M | $354M | $343M | $317M |
| High | $307M | $363M | $353M | $326M | $297M | $366M | $354M | $327M |
| Net Income Avg | $118M | $185M | $143M | $136M | $117M | $197M | $158M | $145M |
| Low | $110M | $179M | $141M | $134M | $116M | $195M | $156M | $143M |
| High | $163M | $202M | $147M | $140M | $121M | $203M | $162M | $149M |
| EPS Avg | $0.39 | $0.62 | $0.48 | $0.45 | $0.39 | $0.66 | $0.53 | $0.49 |
| Low | $0.37 | $0.60 | $0.47 | $0.45 | $0.39 | $0.65 | $0.52 | $0.48 |
| High | $0.55 | $0.68 | $0.49 | $0.47 | $0.40 | $0.68 | $0.54 | $0.50 |
| Analysts (Rev / EPS) | 9 / 14 | 8 / 10 | 4 / 4 | 7 / 4 | 4 / 4 | 7 / 4 | 3 / 5 | 6 / 5 |